Margatoxin

A potent and specific KV1.3 channel blocker, and exhibits no effect at calcium-activated channels. Margatoxin can reduces VEGF-induced transmembrane calcium influxes and nitric oxide production in human endothelial cells.

Online Inquiry

CAT#R0995
CAS145808-47-5
Synonyms/AliasMgTX
M.F/FormulaC178H286N52O50S7
M.W/Mr.4178.96
SequenceTIINVKCTSPKQCLPPCKAQFGQSAGAKCMNGKCKCYPH
(Disulfide bridge between Cys7 and Cys29, Cys13 and Cys34, Cys17 and Cys36)
Labeling TargetKV1.3 channel
AppearanceWhite lyophilised solid
Purity>98%
ActivityBlocker
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

 GR 64349 is a selective and potent NK2 agonist (EC50 = 3.7 nM in rat colon) with activity comparable to that of ...

 The β-amyloid precursor protein (APP) is connected to Alzheimer's disease by both biochemistry and genetics. As ...

 Elcatonin acetate, a physicochemically and biologically stable synthetic derivative of calcitonin transformed fr ...

 PMX-53, a chemically synthesized peptide material, is a potent C5a antagonist in human neutrophils and macrophag ...

 Acid-sensitive ion channels (ASICs) are a class of proton-gated ion channels belonging to the Degenerin/Epitheli ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.